Depression at NEI Fall Congress 2026
4 sessions on depression · November 5–8, 2026, Colorado Springs, CO. Compare depression at other meetings →
Thursday, November 5
Workshop · Pre-Conference Workshop: Sleep
The Fate of Orexins: Their Expanding Role in Insomnia, Hypersomnia, and Depression
Covers orexin system physiology and the growing therapeutic role of orexin receptor antagonists and agonists across insomnia, hypersomnia, and mood disorders.
Symposium
Switching Gears in MDD: When, Why, and How to Use Glutamatergic Therapies to Optimize Functional Outcomes
Andrew J. Cutler · Kristian Dambrino
When and how to deploy glutamatergic agents in major depressive disorder to improve functional recovery.
Symposium
Efficacy, Acceptability, and Accessibility and Accessibility of SDA-PAs: Shared Decision Making in the Selection and Sequencing of Treatments for MDD
Roger S. McIntyre · Thomas L. Schwartz
Applies shared decision-making to selecting and sequencing serotonin-dopamine activity partial agonists among MDD treatment options. Title reproduced exactly as published on the agenda.
Saturday, November 7
Symposium
Hormones Gone Wild? Depression Across the Female Lifespan From Puberty to Perimenopause
Examines hormonally influenced depression across reproductive stages from puberty through perimenopause.
Other topics at this meeting
Child & Adolescent 5Neuroscience & Mechanisms 5ADHD 3Antipsychotic Prescribing 3Tardive Dyskinesia & Movement Disorders 3Sleep & Insomnia 3Anxiety Disorders 2Deprescribing & Polypharmacy 2Practice, Policy & Workforce 2Schizophrenia & Psychosis 2Serious Mental Illness 2Stimulants & ADHD Medications 2